Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. clinical trials
Also known as FDZJ.
The registry lists 25 studies whose lead sponsor is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 28, 2026.
Keep track of what changes. Save the Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd..
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.25 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 25 of 25.
- A Study of FZ-AD004 in Patients With Advanced Solid TumorsRecruitingNCT05914545Phase 1
- A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)Not yet recruitingNCT07455045Phase 1
- A Study of FZ-AD005 in Patients With Advanced Solid TumorsRecruitingNCT06424665Phase 1
- A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDTRecruitingNCT05171894Phase 2
- A Study of FDA022-BB05 in Advanced/Metastatic Solid TumorsRecruitingNCT06413615Phase 2
- A Study of FDA022-BB05 in Subjects With Advanced Solid Malignant TumorsRecruitingNCT05564858Phase 1
- Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic Acid(5-ALA)CompletedNCT06417281Phase 3
- A Study of FDA018-ADC in Patients With Advanced Solid TumorsActive, not recruitingNCT05174637Phase 1
- FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast CancerActive, not recruitingNCT06519370Phase 3
- Phase 1 Study to Evaluate Safety and Pharmacokinetics of FZJ-003 in Healthy VolunteersCompletedNCT04715529Phase 1
- Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary CirrhosisCompletedNCT06715319Phase 3
- ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV InfectionCompletedNCT06439433Phase 2
- A Study of F0002-ADC in Chinese Patients With Refractory or Recurrent CD30+ Hematologic Malignancies.CompletedNCT03894150Phase 1
- A Pilot Study of Hemoporfin PDT in Children(2-7 Years Old) With Port-wine StainCompletedNCT04106258Phase 4
- Postmarketing Safety Study of Hemoporfin in Patients With Port Wine StainCompletedNCT03181984Phase 4
- Pharmacokinetics and Safety of ALA in Acne VulgarisCompletedNCT04044898Phase 1
- A Pilot Study of Hemoporfin PDT in Children With Port-wine StainCompletedNCT03125057Phase 4
- A Study on Safety and Preliminary Efficacy of ALA in Acne VulgarisCompletedNCT04018885Phase 1/2
- Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar CholangiocarcinomaTerminatedNCT02955771Phase 2
- Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese VolunteersCompletedNCT02291471Phase 1
- Tolerance, Pharmacokinetics and Preliminary Efficacy of T0001 in RA (Rheumatoid Arthritis)TerminatedNCT02481180Phase 1
- Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)CompletedNCT02631863Phase 2
- Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical NeoplasiaCompletedNCT02304770Phase 2
- Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian CancerCompletedNCT02237690Phase 1
- Deuteporfin Tolerance and Pharmacokinetics in Healthy VolunteersCompletedNCT01481597Phase 1